Pharmacology glossary
Biological half-life and steady state: what concentration-time summaries assume
Elimination half-life describes how long a modeled concentration takes to fall by half under stated conditions. Steady state describes a dynamic balance between input and elimination, not the moment a compound becomes effective or safe.
Educational content only. Not medical advice.
Half-life depends on the phase being described
Concentration can fall rapidly during distribution and more slowly during terminal elimination. A report should identify whether it presents distribution, effective, or terminal half-life and how the slope was estimated. In simple first-order models, a constant fraction is removed per unit time; in nonlinear or target-mediated systems, the apparent half-life can change with concentration.
Clearance and distribution jointly influence elimination half-life
A longer half-life can reflect lower clearance, wider apparent distribution, or both. It does not necessarily mean stronger target engagement or longer clinical benefit. Assay sensitivity, sampling duration, metabolites, and binding can also alter the terminal phase that investigators can observe and estimate.
Steady state is a dynamic balance
Under repeated or continuous input and stable linear kinetics, concentrations approach a repeating or stable pattern when average input equals average elimination. The commonly cited relationship between several half-lives and approach to steady state is an approximation that depends on the model. Changing clearance, time-dependent biology, immune responses, or nonlinear kinetics can violate it.
Read the curve, assumptions, and uncertainty
Check sampling duration, terminal-phase points, model fit, participant variability, confidence intervals, and whether concentrations fell below quantification. A half-life copied from a different species, formulation, or assay may not transfer. This page supports interpretation of research reports and intentionally provides no scheduling or personal-use guidance.
Evidence limits
- One reported half-life may summarize only a selected terminal phase of a complex curve.
- Steady-state approximations assume stable kinetics that may not hold for every compound.
- Population averages can hide substantial between-participant variability.
Sources and further reading
These sources ground the definitions and evidence boundaries on this page. A citation is a route for verification, not an endorsement of a product or personal use.
StatPearls, NCBI Bookshelf
Elimination Half-Life of Drugs
Authoritative explanation of elimination half-life, first-order assumptions, clearance, and distribution.
Open sourceStatPearls, NCBI Bookshelf
Steady State Concentration
Authoritative background on steady state as a dynamic relationship between input and elimination.
Open sourceStatPearls, NCBI Bookshelf
Pharmacokinetics
Authoritative educational synthesis of absorption, distribution, metabolism, elimination, clearance, and exposure measures.
Open sourceCommon questions
Does half-life equal duration of effect?
No. Pharmacodynamic effects can end before or persist after measured concentrations decline.
Is steady state a fixed concentration?
It can be a stable average or a repeating peak-trough pattern, depending on the input and model.
Can a compound have more than one half-life?
Yes. Multi-phase distribution and elimination can produce different descriptive half-lives.
Continue with context
Keep building your evidence-reading skills
Explore the public PeptideSchool research library for more source-backed methods, glossaries, and evidence maps.